Atlas Trials

Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)

Clinical trial NCT04858529 · UNKNOWN

Trial details

NCT number
NCT04858529
Sponsor
Guangdong Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Neoadjuvant Therapies for HER2+ Breast Cancer
Start date
2021-04-30
Primary completion
2024-04-30
Enrollment
774

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.